Patient Guide: GS-US-457-6411: A Phase 2 Double-Blinded Randomized Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of GS-5290 in Participants with Moderately to Severely Active Ulcerative Colitis

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTGS-US-457-6411
Status: 🟢 Enrolling Now
Condition: Ulcerative Colitis
Phase: PHASE2

Loading interactive enrollment tools...

The full interactive experience will load momentarily